Humanized emap II MAB as a novel therapy for viral-associated lung injury
Ended Project Grant Awarded Last action
- Award ID
- R41HL135945
- Recipient
-
Allinaire Therapeutics, LLC UEI K5GFMW6QF1P7
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $281,155
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Beachwood, OH 44122, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $281,155 |
Quick answers
Who received award R41HL135945?
R41HL135945 was awarded to Allinaire Therapeutics, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on February 15, 2018.
How much is award R41HL135945 worth?
$281,155 has been obligated on R41HL135945.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award